JP2011512362A5 - - Google Patents

Download PDF

Info

Publication number
JP2011512362A5
JP2011512362A5 JP2010546952A JP2010546952A JP2011512362A5 JP 2011512362 A5 JP2011512362 A5 JP 2011512362A5 JP 2010546952 A JP2010546952 A JP 2010546952A JP 2010546952 A JP2010546952 A JP 2010546952A JP 2011512362 A5 JP2011512362 A5 JP 2011512362A5
Authority
JP
Japan
Prior art keywords
composition
topical
composition according
item
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010546952A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011512362A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/034219 external-priority patent/WO2009103053A1/en
Publication of JP2011512362A publication Critical patent/JP2011512362A/ja
Publication of JP2011512362A5 publication Critical patent/JP2011512362A5/ja
Withdrawn legal-status Critical Current

Links

JP2010546952A 2008-02-15 2009-02-16 眼科応用のためのフルオロキノロン誘導体 Withdrawn JP2011512362A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2918008P 2008-02-15 2008-02-15
PCT/US2009/034219 WO2009103053A1 (en) 2008-02-15 2009-02-16 Fluoroquinolone derivatives for ophthalmic applications

Publications (2)

Publication Number Publication Date
JP2011512362A JP2011512362A (ja) 2011-04-21
JP2011512362A5 true JP2011512362A5 (https=) 2013-02-21

Family

ID=40551911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010546952A Withdrawn JP2011512362A (ja) 2008-02-15 2009-02-16 眼科応用のためのフルオロキノロン誘導体

Country Status (11)

Country Link
US (3) US20090209574A1 (https=)
EP (1) EP2249836A1 (https=)
JP (1) JP2011512362A (https=)
KR (1) KR20100125318A (https=)
CN (1) CN101977604A (https=)
AU (1) AU2009214461A1 (https=)
BR (1) BRPI0907511A2 (https=)
CA (1) CA2714580A1 (https=)
MX (1) MX2010008927A (https=)
WO (1) WO2009103053A1 (https=)
ZA (1) ZA201005790B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
RU2014127492A (ru) 2011-12-06 2016-02-10 Алькон Рисерч, Лтд. Композиции целлюлозного геля с улучшенной стабильностью вязкости
US9504691B2 (en) * 2012-12-06 2016-11-29 Alcon Research, Ltd. Finafloxacin suspension compositions
US9630909B2 (en) 2013-06-27 2017-04-25 Mylan Laboratories Ltd Process for the preparation of nepafenac
WO2017151664A1 (en) * 2016-02-29 2017-09-08 Belmont University Pharmaceutical compositions for fluoroquinolone drug delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880517A (en) * 1984-10-01 1989-11-14 Eltech Systems Corporation Catalytic polymer electrode for cathodic protection and cathodic protection system comprising same
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US6440964B1 (en) * 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
US6740664B2 (en) * 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6716830B2 (en) * 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin

Similar Documents

Publication Publication Date Title
IL176416A (en) History of Nitroxy prostaglandin, pharmaceutical preparations containing them, and their use in the preparation of the drug for the treatment of glaucoma or intraocular pressure
JP2002525317A5 (https=)
JP2010511729A5 (https=)
WO2007129195A3 (en) 4-pyrimidine-5-amino-pyrazole compounds
WO2009109613A3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
JP2011512362A5 (https=)
WO2009063202A3 (en) Use of crth2 antagonist compounds
WO2012107706A8 (en) Phenothiazine diaminium salts and their use
JP2011521969A5 (https=)
WO2010136474A3 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
WO2009082819A8 (en) Novel lupane derivatives
JP2003505422A5 (https=)
JP2012531448A5 (https=)
WO2010098600A3 (en) Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
WO2009109616A8 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
JP2015025011A5 (https=)
EP3069720A8 (en) Pharmaceutical composition containing glutarimide derivatives, and application thereof for treating eosinophilic diseases
RU2009119912A (ru) Аминные производные и их применение в бета-2-адренорецептор-опосредованных заболеваний
JP2012520882A5 (https=)
WO2009013348A3 (en) Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
TW200815410A (en) Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
WO2010005580A3 (en) Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity
AU2017261303A1 (en) Ophthalmic compositions
RU2011112684A (ru) АГЕНТ, СПОСОБСТВУЮЩИЙ РОСТУ ВОЛОС, СОДЕРЖАЩИЙ В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА ПРОИЗВОДНОЕ 15,15-ДИФТОРПРОСТАГЛАНДИНА F2α
HK1222337A1 (zh) 用於施加药物活性成分或化妆品活性成分的局部组合物和载体